Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for regression of left ventricular hypertrophy in treated hypertension
2014-002083-33Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in left ventricular hypertrophy (LVH) comparing Allopurinol with Placebo (2 arms). Primary endpoint: Change in left ventricular mass index. Started Jun 2014; status: completed.
02
Drugs
allopurinol
03
Conditions
left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on 2014-002083-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002083-33.